Objective To assess the effect of maternal low flow oxygen administration during the second stage of labour on umbilical cord artery pH.
Introduction
The use of oxygen for intrauterine resuscitation has a history of more than seven decades; clinical practice is so ingrained that most obstetricians and midwives administer oxygen intuitively at the first signs of non-reassuring fetal heart rate (FHR) and prophylactically in the second stage of labour. 1, 2 It is estimated that every year over half of all labours (3.2 million) receive supplemental oxygen in the USA; however, evidence of hypoxaemia does not actually exist in these women. 2 Despite this widespread use, the effect of supplementary maternal oxygen is still debated. 3, 4 Some studies confirmed that oxygen supplementation increased the partial pressure of dissolved oxygen (PO 2 ) in maternal brain and placenta but without a detectable PO 2 increase in fetal brain. 5, 6 Other papers found that oxygen given to the mother did increase fetal oxygen saturation. 7, 8 There is not enough evidence to support the current American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin which recommends maternal oxygen for intrauterine resuscitation. 9 To date there have been no randomised controlled trials (RCTs) concerning maternal oxygen administration for non-reassuring FHR and there are only two small RCTs addressing prophylactic oxygen administration in the second stage of labour. 1 Thorp et al. 10 randomised 86 women in normal labour at the onset of second stage to receive face mask oxygen at 10 l/ min or no oxygen, and found that an umbilical artery pH of less than 7.20 was significantly more frequent in the oxygen group than in the control group (9/41 versus 2/44). Sirimai et al. 11 randomised 160 women in normal labour to receive either oxygen in the second stage or no oxygen, and reported a similar result but with no statistically significant difference (8/80 versus 3/80). It is becoming recognised that hyperoxia causes vasoconstriction by uncertain mechanisms, and the effects have been observed on coronary, cerebral, renal and other key vasculatures in healthy adults. 12 It is also known that human vessels of placenta and umbilical cord are highly sensitive to hyperoxia and constrict in vitro. 10 Tissue perfusion decreases may be more important than increases in arterial PO 2 , which is why supplemental oxygen for intrauterine resuscitation may be potentially harmful. 2 This study was designed to assess the effect of the use of maternal low flow nasal oxygen (2 l/ min) on umbilical cord artery pH during the second stage of labour.
Methods
The trial was carried out at the Department of Obstetrics and Gynaecology, Navy General Hospital, Beijing, China, from September 2014 to May 2015. The tertiary teaching hospital has 3000 deliveries annually. Institutional Review Board Project No. 08/29/2014 was approved on 29 August 2014 by the Navy General Hospital Ethics Committee. The trial was registered with the clinicaltrials.gov register with the identifier NCT02221440 before its commencement.
Study design
Inclusion criteria were: maternal age less <35 years, at term (>37 weeks, <42 weeks), singleton, nulliparous, cephalic presentation, spontaneous or induced labour, normal FHR tracings in the first stage, normal labour at the onset of second stage. Exclusion criteria were: pregestational or insulin-treated diabetes mellitus, hypertension, pre-eclampsia or eclampsia, oligohydramnios, fetal growth restriction, placental abruption, cephalopelvic disproportion, meconium -tained amniotic fluid, tachysystole, having received oxygen in the first stage, uterine incision (myomectomy or perforation), respiratory or cardiovascular disease, anaemia, fever, disorders in oxygen saturations, hypotension, tobacco or alcohol use.
Management of labour was determined by attending obstetricians who had no part in this study. Patients were asked to participate on admission; informed consent was obtained before/during the first stage of labour. A 1:1 random sequence was generated using a table of random numbers by one investigator (L.C.) who took no further part in this study. Randomisation was performed by the sequential opening of sealed numbered envelopes when the cervix was completely opened up, after confirmation of consent. Patients randomised to the experimental group received oxygen administered by the nasal cannula at a flow rate of 2 l/min (chosen because haemoglobin would be saturated at about this level). Control group patients received a sham supplementation by supply of room air by the nasal cannula at a flow rate of 0 l/min. Patients were encouraged, but not forced, to breathe through their noses. The flow rates were set by a research nurse who played no further part in the trial, and supplementation was continued until after delivery. The oxygen rotameter was always concealed within an opaque bag to blind healthcare providers and patients. Outcome assessors were also blinded to allocation.
Baseline characteristics of all women were collected, including maternal age, gestational age, gravidity, body mass index (BMI), antepartum haemoglobin and haematocrit, labour onset, methods used to induce labour, use of oxytocin during labour, pain management, and duration of first stage of labour. All participants gave birth in a supine position. Electronic FHR monitoring was reviewed every 30 minutes in the first stage of labour and continuously during the second stage. Fetal scalp blood sampling was not used in this study. The three-tiered interpretation system was used to manage the non-reassuring FHR as recommended by the ACOG Practice Bulletin and the techniques of intrauterine resuscitation included the following: discontinuation of oxytocin, vaginal examination to determine umbilical cord prolapse or rapid cervical dilation, changing maternal position to left or right lateral recumbent position, monitoring maternal blood pressure, and assessment of uterine tachysystole. 13 Tocolytic agents and amnioinfusion were not used in this study.
Outcome measures
Primary outcome was umbilical cord artery pH. Secondary outcomes were: degree of maternal satisfaction, method of delivery, FHR pattern, tachysystole, hypotension, meconium-stained amniotic fluid, use of oxytocin during labour, duration of second stage of labour, maternal radial arterial blood gas, postpartum haemoglobin and haematocrit, neonatal sex, birthweight, umbilical length and state, placental weight, Apgar score, resuscitation, umbilical cord artery base excess, admission to neonatal intensive care, neonatal encephalopathy, and serious neonatal morbidity.
The umbilical cord artery blood sample was collected as recommended by ACOG with some modifications.
14 A segment of umbilical cord (15-20 cm) was double-clamped and cut off immediately after delivery, the umbilical cord vein was identified, opened and emptied, and artery blood sample from either of the two umbilical cord arteries was used for blood gas analysis. Maternal satisfaction was investigated by a Likert rating scale questions based on four items (overall labour experience, smoothness of breathing, foreign body sensation, and whether she would consider receiving the supplementation in her next labour), and a composite score of the total 20 points was calculated. A maternal radial arterial blood sample was obtained in women with the cannulas still in place, who voluntarily agreed immediately after delivery. Complete blood count was performed on admission and 24 hours after delivery. All newborns were followed up during the first month after birth.
Statistical analysis
Sample size was calculated based on the umbilical cord artery pH. A clinically significant change of umbilical cord artery pH was assumed to be 0.02 pH units. 2 The mean umbilical cord artery pH was approximately 7.28 in term infants (standard deviation 0.07 pH units). 2 To detect the 0.02 difference in pH with 80% power and a two-sided significance of 0.05, we estimated that 193 participants were needed in each group. We anticipated a 10% loss to follow up, resulting in our plan to enroll 430 women.
Statistical analysis was performed using SPSS Statistics 22.0 (IBM Corporation, Armonk, NY, USA). The Kolmogorov-Smirnov test was used to analyse the normal distribution of continuous variables. Student's t test was used for normal distributed variables and the Mann-Whitney U test was used for abnormal distributed variables. Chi-square test or Fisher exact test was used to analyse categorical variables. Data are expressed as median (interquartile range, IQR), mean (standard deviation, SD), or number (%). Treatment effect, relative risk (RR) or mean difference (MD), with a 95% confidence interval (CI) was calculated using REVIEW MANAGER version 5.3 (Cochrane Collaboration, London, UK). P < 0.05 was taken as statistical significance.
Results Figure 1 shows the trial flow diagram. There were 219 women who were assigned to oxygen supplementation and 224 who were assigned to sham supplementation. All women in the two groups were available for follow-up and analysis. The baseline characteristics were similar between the two groups ( Table 1) .
There were no significant differences between the oxygen supplementation and the sham supplementation groups in the umbilical cord artery pH [median 7.261 (IQR 7.228- Only four infants had an Apgar score less than 7 at 1 minunte in the oxygen supplementation group, and three infants in the sham supplementation group. Neonatal encephalopathy was not detected in any neonate. In the oxygen supplementation group, one infant had a pulmonary haemorrhage immediately after delivery without known cause. In the sham supplementation group, one infant was diagnosed with ABO haemolytic disease of newborn on the third day and treated by exchange transfusion, and one infant was infected with Staphylococcus aureus on the 20th day (Tables 2 and 3) .
Maternal arterial blood samples were provided by 107 women in the oxygen supplementation groups and 110 in the sham supplementation group. The maternal PO 2 was significantly higher in the oxygen supplementation group [median 150.0 mmHg (IQR 142.6-156.7) versus 112.0 mmHg (IQR 104.8-118.3), P < 0.001]; however, the maternal PCO 2 was significantly lower [26.1 mmHg (SD 4.1) versus 27.2 (3.4), MD À1.1 (95% CI À2.1 to À0.1), P = 0.03] (Table S1 ).
Discussion

Main findings
The present study showed that supplemental low flow nasal oxygen at 2 l/min in normal women during the second stage of labour did not adversely effect either the umbilical artery pH or the FHR pattern distribution. There were also no significant differences between the two groups in most of the other secondary outcomes, including the degree of maternal satisfaction, and the need for assisted vaginal delivery, caesarean section or neonatal resuscitation. In the non-random samples for blood gas analysis, we confirmed that the use of low flow oxygen supplementation increased the maternal PO 2 but decreased the maternal PCO 2 significantly.
Strengths and limitations
This RCT had adequate power for a clinically significant difference in the primary outcome, employed a sham supplementation for control and captured 100% of all outcome data, yet has some important limitations. The primary outcome, umbilical cord artery pH, is a laboratory finding rather than a clinically relevant outcome such as neonatal encephalopathy. In a large cohort study with 51 519 neonates, the absolute risk of an adverse neurological outcome was increased below pH 7.10 (0.36%) and was lowest between pH 7.26 and 7.30 (0.16%), but more than 75% of neonates with neurological sequelae had a pH above 7.10, suggesting a weak relationship between neonatal acidaemia and serious neurological outcomes. 15 As many as 11 000 women would be required to detect differences of the serious neonatal morbidity between the two groups 2 so, unsurprisingly, we observed no cases of encephalopathy in our trial. Exact arterial oxygen content could not be determined, as it was difficult to control the fraction of inspired oxygen through the nasal cannulae because of the variability of the degree of dilution with room air, tidal volume, respiratory rate, anatomic dead space, and the impact of an open or closed mouth. 16 We only considered one concentration of oxygen supplementation, so the results cannot be extrapolated to higher flow rates. Fewer than half the participants (217/443) provided samples for radial arterial blood gas analysis. We did not have an ideal method of noninvasive and continuous measurement of the blood gas.
Finally, the most pertinent clinical question is the impact of oxygen supplementation for labour where there is an abnormal FHR, which were excluded in our study. A Cochrane review located no RCTs, illustrating the difficulty in addressing this question. 1 Our trial is only applicable to the low risk participants but nonetheless provides data on the impact of low flow oxygen on fetal acid-base status.
Interpretation
To our knowledge, this is the first randomised trial of low dose oxygen for intrauterine resuscitation, in contrast to previous studies including Thorp et al. 10 (face mask at 10 l/min), Jozwik et al. 17 (60% oxygen, face mask at 15 l/min), Lawes et al. 18 (50% or 33% oxygen) and Simpson et al. 8 (face mask at 10 l/ min). At the low level of oxygen, we did not find a harmful effect; however, we still could not demonstrate any benefit in preventing low umbilical cord artery pH.
Despite the widespread use of oxygen in intrauterine resuscitation, there is no guideline that codifies its indication, metabolism, dose range, duration and curative effect. Supplemental maternal oxygen has been employed for many years on the assumption that a nonreassuring FHR pattern implied that a fetus was poorly oxygenated, 13 supported by many non-randomised trials showing that oxygen therapy increased fetal oxygen saturation and alleviated nonreassuring FHR pattern. 2 Studies showed that late deceleration was the outcome of fetal hypoxia, and it could be reversed in primates by increasing PO 2.
19,20 However, our findings contrast with the previous two small RCTs, which showed that prophylactic oxygen during the second stage of normal labour was potentially harmful. 10, 11 There is a growing awareness that hyper PO 2 may induce tissue hypoxia, and oxygen should not be abused in many situations, such as stroke, critical care, coronary artery disease, myocardial infarction, chronic obstructive pulmonary disease, especially when a patient is not lacking oxygen. 12 Fetuses are not usually so oxygen-depleted that they need supra-physiologic oxygen supplementation. In general, maternal arterial PO 2 is much higher than umbilical venous PO 2 , invariably >100 versus around 28 mmHg respectively; however, the excess maternal PO 2 can not cause hypoxia in fetuses. 21 The concentration of fetal hemoglobin is significantly higher than that of maternal haemoglobin (median 165 versus median 125 g/l), and the carrying capacity of fetal haemoglobin (HbF, a2c2) is much greater than that of adult haemoglobin (HbA, a2b2). 2 The maternal delivery of oxygen outweighs fetal demand, even when the oxygen supply is reduced by half. 22 It is well known that oxygen transport is dependent mainly on haemoglobin, around 98.5% total oxygen combine in haemoglobin and only about 1.5% total oxygen exists in the physical dissolution. Based on the oxygen dissociation curve, the haemoglobin of oxygen saturation will not change much (from 90 to 97.4%) within the range of 60 mmHg PO 2 and 100 mmHg PO 2 , and haemoglobin will be saturated by oxygen at about the 150 mmHg PO 2 .
23 When all haemoglobin is already saturated, excess oxygen has to dissolve in the blood, 23 a very inefficient route; there is only an increase 0.03 ml/l per mmHg PO 2 under one atmospheric pressure. 23 In this trial, nasal cannula at 2 l/min oxygen (24-33% oxygen) 24 increased the maternal arterial PO 2 to the median 150 mmHg, range 135.1-177 mmHg. However, the vasoconstrictor effects of hyper PO 2 would decrease tissue perfusion to a greater extent than the minimal arterial oxygen content increase beyond haemoglobin saturation. 12 Our results showed that the maternal PCO 2 (mmHg) was slightly lower in the oxygen supplementation group than in the sham supplementation group, which might be caused by hyper PO 2 . 
Conclusion
We conclude that maternal low flow oxygen administration in normal labour does not provide any evidence of detrimental effects on umbilical artery pH, as it is not associated with a lower pH compared with a sham intervention.
In the absence of data on adverse neonatal outcomes, we do not seek to reach a conclusive recommendation regarding low-dose oxygen supplementation.
Disclosure of interests
None declared. Completed disclosure of interests form available to view online as supporting information. 
Contribution to authorship
Funding
Not applicable.
